在患有系统性硬化症的人群中,根据疾病亚型,语言,性别和年龄对患者健康问卷-8的差异性项目运作:一种以硬化症为中心的患者干预网络队列研究
Sophie Hu1,2, Marie-Eve Carrier1, Marie-Claude Geoffroy2,3
1Lady Davis Institute of the Jewish General Hospital, Montreal, Quebec, Canada.
Arthritis care & research
|January 20, 2026
概括
八项患者健康问卷 (PHQ-8) 在全身性硬化症 (SSc) 亚型,语言,性别或年龄方面没有显著的偏见. 这种抑郁症评估工具对各种患者群体,包括SSc.患者可靠.
科学领域:
- 类风湿病学和精神病学
- 心理测量验证健康结果的措施.
背景情况:
- 抑郁症评估中的身体症状可能会与系统性硬化症 (SSc) 等身体疾病重叠.
- SSc亚型 (扩散与有限) 对抑郁症症状报告的影响尚不清楚.
- 八项患者健康问卷 (PHQ-8) 是一种常见的抑郁症评估工具.
研究的目的:
- 为了评估PHQ-8在SSc亚型中的差异性项目功能 (DIF).
- 通过语言,性别和年龄来评估PHQ-8 DIF.
主要方法:
- 分析了2191名参与者,这些参与者来自于硬皮肤病患者为中心的干预网络队列.
- 确认因素分析 (CFA) 来确认PHQ-8的单维性.
- 多个指标多个原因 (MIMIC) 模型用于DIF分析.
主要成果:
- PHQ-8 展示了一个强大的单因素结构.
- 对于SSc亚型,没有发现具有统计意义的DIF.
- 在语言,性别和年龄方面检测到轻微的DIF,但对整体得分的影响微不足道.
结论:
- PHQ-8适用于评估系统性硬化症患者的抑郁症,无论疾病的亚型如何.
- 在这个队列中,PHQ-8在不同语言,性别和年龄组中表现一致.
相关概念视频
Patient-centered Care
2.9K
Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
2.9K
Pharmacodynamics in Geriatric Patients: Effects of Age
191
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
191
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
230
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
230
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
234
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
234
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
199
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
199
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
243
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
243


